CD146 is a potential immunotarget for neuroblastoma.

Cancer Sci · 2021 · PMC8586675 · PMID 34464480

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

of borderline significanceP =.093so close (0.05 < p ≤ 0.1)

There was also a difference in tumor weight, although this was of borderline significance ( P =.093; Figure 5E ).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.